Stay updated with breaking news from Coverage With Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As CMS establishes itself as an HTA entity, it may consider carving out the HTA function and delegating it to an external entity that can operate as a neutral arbiter.
Decision looms that could determine fate of Alzheimer’s drug
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.